Welcome to our dedicated page for CARECLOUD news (Ticker: CCLDO), a resource for investors and traders seeking the latest updates and insights on CARECLOUD stock.
News for CareCloud, Inc. 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (Nasdaq: CCLDO) is closely tied to the operating and capital markets activities of CareCloud, Inc., a healthcare technology and AI-focused company. Investors following CCLDO typically monitor company announcements about preferred stock dividends, redemption terms, financial performance, acquisitions, and AI product launches, since these developments provide context for the preferred security.
CareCloud regularly issues press releases detailing its preferred stock dividend policies and payments. For the Series B Preferred Stock, the company has announced monthly cash dividends, described the cumulative nature of those dividends, and outlined record and payment dates. It has also communicated plans to address accumulated dividend arrears on the Series B Preferred Stock through double monthly dividend payments that combine regular dividends with catch-up payments until past due amounts are fully satisfied.
Beyond dividend-specific updates, the news flow includes information about CareCloud’s broader business performance and strategy. The company has reported quarterly financial results, discussed revenue guidance, and highlighted periods of positive GAAP net income and adjusted EBITDA. It has also described acquisitions such as Medsphere’s hospital IT business and HFMA’s MAP App, which expand its presence in hospital and integrated health system markets and support its AI-driven revenue cycle and benchmarking capabilities.
CareCloud’s news also covers AI product introductions and enhancements, including the launch of stratusAI Desk Agent, an AI phone receptionist for patient access, and the integration of stratusAI Voice Audit for conversational intelligence and call analytics. Additional announcements describe the deployment of the Wellsoft emergency department information system in urgent care settings and the company’s AI Center of Excellence, which supports innovation across inpatient and ambulatory EHR, RCM, analytics, and patient engagement.
Investors and observers who track CCLDO can use this news stream to see how CareCloud’s dividend practices, redemption options, AI initiatives, acquisitions, and financial performance evolve over time. These updates provide insight into both the preferred stock’s income characteristics and the underlying healthcare technology platform that supports the issuer.
CareCloud, Inc. has retained Citizens JMP as its exclusive capital structure advisor after receiving an unsolicited indication of interest to acquire the company. The Board of Directors declined the proposal and Citizens JMP will evaluate CareCloud's capital structure for potential modifications to its Series A Preferred Stock.
CareCloud, Inc. partners with NJ Comprehensive Healthcare to enhance operational efficiency and reduce costs. NJCH adopts CareCloud's talkUltimate suite for revenue cycle management, electronic health records, and practice management solutions, aiming to streamline processes and boost workflow efficiency.
CareCloud, Inc. will announce its first-quarter 2024 financial results on May 14, 2024. The company is a prominent provider of healthcare technology solutions in the medical industry. The results will be disclosed before the market opens, followed by an investor conference call at 8:30 a.m. Eastern Time. Interested parties can access the live webcast and presentation slides on the company's investor relations website. A replay will also be available shortly after the call.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of CARECLOUD (CCLDO)?
